The U.S. Is Building a Massive Database of Public Health Data
More than six million Americans currently live with Alzheimer’s. By 2050, more than 13 million Americans may develop the condition. But despite decades of…
More than six million Americans currently live with Alzheimer’s. By 2050, more than 13 million Americans may develop the condition. But despite decades of…
Almost 50 million Americans each year use some form of cannabis. In the 1920s, the drug was vilified because of recreational use by Mexican…
After almost two decades of stagnation, two new drugs for Alzheimer’s have hit the market in the last three years. The approval of Biogen…
The human gut is home to trillions of microscopic organisms — collectively called the microbiome. The bacteria in the gut help digest food; they…
Despite decades of study, the underlying cause of Alzheimer’s continues to evade scientists. Because it’s such a mystery, there are only six drugs approved for…
In June, the Food and Drug Administration will decide whether to grant full approval to Biogen and Eisai’s anti-amyloid Alzheimer’s drug Leqembi (generic name…
As Julie Fleming’s father slipped into the later stages of Alzheimer’s dementia, she could only watch as his computer skills and interests faded. “The…
After coming down with the flu during the 1918 influenza pandemic, more than one million people developed a virus-induced form of Parkinson’s disease, with…
As many as one in three people with Alzheimer’s disease experience hallucinations: They see, hear, smell or otherwise sense things that aren’t actually there….
While other cognitive functions and memories fade away with dementia, musical memories are last to go. Music transports patients to a comfortable moment in…
Would you take a supplement — for example, brain health supplement Neuriva Plus — that claims to boosts your brain function? After all, Mayim…
Inflammation is a hallmark of neurodegenerative diseases including multiple sclerosis (MS) and Alzheimer’s disease. The amyloid hypothesis still dominates in the conversation about what…
This article is part of the series Diversity & Dementia, produced by Being Patient with support provided by Eisai. “I was driving home from work and…
The appeal of brain boosting pills is obvious: a simple solution that supports cognitive function, making you sharper, improving your memory. This sort of…
Early this year, the Food and Drug Administration (FDA) granted accelerated approval to a new anti-amyloid treatment developed by Eisai and Biogen, Leqembi. In…